GlassScriptPhysician profile
Mitchell R Waskin
NPI 1528052115
$2,349.16
in general payments reported to CMS, 2019-2025
27 companies · $643 in 2025
The $643 reported for 2025 was more than what 78% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $58.36 · 2021: $35.96 · 2022: $108 · 2023: $283 · 2024: $1,091 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,017.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $351.49 | 2019-2025 | Affinity, Puraply, Simplimax |
| Reddress USA, INC. | $292.34 | 2024-2025 | Actigraft |
| Abbvie INC. | $269.11 | 2024 | |
| Kerecis Limited | $219.15 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $210.63 | 2022-2024 | Stravix, Grafix, Renasys Go V2 Home |
| Medtronic, INC. | $143.50 | 2024 | Venaseal |
| Stryker Corporation | $104.92 | 2019 | |
| Ibsa Pharma INC. | $92.29 | 2023-2024 | Tirosint, Tirosint, Licart |
| Ani Pharmaceuticals, INC. | $88.75 | 2024-2025 | Purified Cortrophin Gel |
| Vertex Pharmaceuticals Incorporated | $70.85 | 2024-2025 | |
| Bioventus LLC | $69.00 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $52.66 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Convatec INC. | $46.40 | 2024-2025 | |
| Abbott Laboratories | $45.15 | 2023 | Proclaim |
| Globus Medical, INC. | $38.38 | 2025 | Senza |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $37.85 | 2023-2025 | Qutenza |
| Lifenet Health | $31.52 | 2025 | Theragenesis Wound Matrix |
| Depuy Synthes Sales INC. | $26.93 | 2024 | Na, N/A |
| Linvatec Corporation | $23.33 | 2020 | |
| Next Science LLC | $23.08 | 2023 | Surgx, Blastx, Xperience |
| Sanara Medtech INC. | $20.79 | 2025 | Celleraterx |
| Reprise Biomedical, INC. | $18.70 | 2024 | Miro3d |
| Sebela Pharmaceuticals INC. | $15.71 | 2020 | |
| Cashflow Solutions, LLC | $15.51 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Tactile Systems Technology INC | $15.05 | 2021 | |
| Mimedx Group, INC. | $13.47 | 2024 | |
| Janssen Pharmaceuticals, INC | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Waskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.